Scope: Research aimed at identifying novel small molecules of CIS and exploring potential uses of CIS inhibitors in a range of normal and disease processes. This project has been expanded to include target validation and structural characterisation for SOCS family proteins, SOCS1 and SOCS2.
Contribution date: From 2015 (ongoing)
Deadline for eligibility: Ongoing